Pharma Mar, S.A. (OTCMKTS:PHMMF) Sees Significant Growth in Short Interest

Pharma Mar, S.A. (OTCMKTS:PHMMF) was the recipient of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 32,700 shares, an increase of 43.4% from the February 13th total of 22,800 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 327.0 days. Approximately 0.2% of the shares of the stock are short sold.

Pharma Mar Stock Performance

Shares of PHMMF stock opened at $102.08 on Tuesday. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The business has a 50-day moving average price of $92.66 and a two-hundred day moving average price of $76.00. Pharma Mar has a 12-month low of $26.85 and a 12-month high of $105.60.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.